These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8049257)
1. Comparison of the sequence specificity of cis-diamminedichloroplatinum (II) damage in guanine- and 7-deazaguanine-containing DNA. Cairns MJ; Murray V Biochim Biophys Acta; 1994 Aug; 1218(3):315-21. PubMed ID: 8049257 [TBL] [Abstract][Full Text] [Related]
2. The use of Taq DNA polymerase to determine the sequence specificity of DNA damage caused by cis-diamminedichloroplatinum(II), acridine-tethered platinum(II) diammine complexes or two analogues. Murray V; Motyka H; England PR; Wickham G; Lee HH; Denny WA; McFadyen WD J Biol Chem; 1992 Sep; 267(26):18805-9. PubMed ID: 1527009 [TBL] [Abstract][Full Text] [Related]
3. Effect of single DNA lesions on in vitro replication with DNA polymerase III holoenzyme. Comparison with other polymerases. Belguise-Valladier P; Maki H; Sekiguchi M; Fuchs RP J Mol Biol; 1994 Feb; 236(1):151-64. PubMed ID: 8107100 [TBL] [Abstract][Full Text] [Related]
4. An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum(II) and four analogues, including two acridine-tethered complexes, with DNA inside human cells. Murray V; Motyka H; England PR; Wickham G; Lee HH; Denny WA; McFadyen WD Biochemistry; 1992 Dec; 31(47):11812-7. PubMed ID: 1445914 [TBL] [Abstract][Full Text] [Related]
5. Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase. Ponti M; Forrow SM; Souhami RL; D'Incalci M; Hartley JA Nucleic Acids Res; 1991 Jun; 19(11):2929-33. PubMed ID: 2057351 [TBL] [Abstract][Full Text] [Related]
6. Bypass of DNA-Protein Cross-links Conjugated to the 7-Deazaguanine Position of DNA by Translesion Synthesis Polymerases. Wickramaratne S; Ji S; Mukherjee S; Su Y; Pence MG; Lior-Hoffmann L; Fu I; Broyde S; Guengerich FP; Distefano M; Schärer OD; Sham YY; Tretyakova N J Biol Chem; 2016 Nov; 291(45):23589-23603. PubMed ID: 27621316 [TBL] [Abstract][Full Text] [Related]
7. Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA. Payet D; Gaucheron F; Sip M; Leng M Nucleic Acids Res; 1993 Dec; 21(25):5846-51. PubMed ID: 8290343 [TBL] [Abstract][Full Text] [Related]
8. Single d(GpG)/cis-diammineplatinum(II) adduct-induced inhibition of DNA polymerization. Suo Z; Lippard SJ; Johnson KA Biochemistry; 1999 Jan; 38(2):715-26. PubMed ID: 9888812 [TBL] [Abstract][Full Text] [Related]
9. A polymerase chain reaction-based method to detect cisplatin adducts in specific genes. Jennerwein MM; Eastman A Nucleic Acids Res; 1991 Nov; 19(22):6209-14. PubMed ID: 1956780 [TBL] [Abstract][Full Text] [Related]
10. Structure of the altromycin B (N7-guanine)-DNA adduct. A proposed prototypic DNA adduct structure for the pluramycin antitumor antibiotics. Sun D; Hansen M; Clement JJ; Hurley LH Biochemistry; 1993 Aug; 32(32):8068-74. PubMed ID: 8347608 [TBL] [Abstract][Full Text] [Related]
11. Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent. Baruah H; Wright MW; Bierbach U Biochemistry; 2005 Apr; 44(16):6059-70. PubMed ID: 15835895 [TBL] [Abstract][Full Text] [Related]
12. Incorporation of De Castro F; Ciardullo G; Fanizzi FP; Prejanò M; Benedetti M; Marino T Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372996 [TBL] [Abstract][Full Text] [Related]
13. Conformation of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II). Schwartz A; Marrot L; Leng M Biochemistry; 1989 Oct; 28(20):7975-9. PubMed ID: 2605168 [TBL] [Abstract][Full Text] [Related]
14. Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid. Broschard TH; Wiessler M; von der Lieth CW; Schmeiser HH Carcinogenesis; 1994 Oct; 15(10):2331-40. PubMed ID: 7955074 [TBL] [Abstract][Full Text] [Related]
15. DNA interactions of a novel platinum drug, cis-[PtCl(NH3)2(N7-acyclovir)]+. Balcarová Z; Kaspárková J; Zákovská A; Nováková O; Sivo MF; Natile G; Brabec V Mol Pharmacol; 1998 May; 53(5):846-55. PubMed ID: 9584210 [TBL] [Abstract][Full Text] [Related]
16. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry. Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396 [TBL] [Abstract][Full Text] [Related]
17. The interaction of DNA-targeted 9-aminoacridine-4-carboxamide platinum complexes with DNA in intact human cells. Temple MD; Recabarren P; McFadyen WD; Holmes RJ; Denny WA; Murray V Biochim Biophys Acta; 2002 Apr; 1574(3):223-30. PubMed ID: 11997087 [TBL] [Abstract][Full Text] [Related]
18. Mutagenic and genotoxic effects of DNA adducts formed by the anticancer drug cis-diamminedichloroplatinum(II). Yarema KJ; Lippard SJ; Essigmann JM Nucleic Acids Res; 1995 Oct; 23(20):4066-72. PubMed ID: 7479066 [TBL] [Abstract][Full Text] [Related]
19. The sequence specificity of the anti-tumour drug, cisplatin, in telomeric DNA sequences compared with consecutive guanine DNA sequences. Murray V; Kandasamy N Anticancer Agents Med Chem; 2012 Mar; 12(3):177-81. PubMed ID: 22044000 [TBL] [Abstract][Full Text] [Related]
20. Structural Basis for Human DNA Polymerase Kappa to Bypass Cisplatin Intrastrand Cross-Link (Pt-GG) Lesion as an Efficient and Accurate Extender. Jha V; Ling H J Mol Biol; 2018 May; 430(11):1577-1589. PubMed ID: 29715472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]